Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.88% | $323.01M | €467.86B | 66.65% | 76 Outperform | |
| Novartis AG | 1.65% | $184.97M | CHF223.13B | 22.27% | 80 Outperform | |
| HSBC Holdings | 1.36% | $152.54M | £224.14B | 56.90% | 80 Outperform | |
| Siemens | 1.23% | $137.94M | €203.14B | 31.60% | 74 Outperform | |
| AstraZeneca | 1.16% | $130.50M | $298.35B | 34.53% | 80 Outperform | |
| SAP SE | 1.13% | $127.02M | €199.37B | -36.17% | 66 Neutral | |
| Nestlé SA | 1.08% | $121.54M | CHF190.98B | 13.70% | 71 Outperform | |
| ABB Ltd | 1.04% | $116.43M | kr1.41T | 36.28% | 78 Outperform | |
| Roche Holding AG | 0.97% | $109.31M | CHF283.12B | 42.92% | 73 Outperform | |
| Schneider Electric | 0.94% | $105.51M | €138.89B | 4.36% | 62 Neutral |